Trial · NCT05178953
The Therapeutic Effect of Co-administration of Pentoxifylline and Zinc in Men With Idiopathic Asthenozoospermia
NCT05178953, Early phase 1, Unknown, Arak University of Medical Sciences
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Therapeutic Effect of Co-administration of Pentoxifylline and Zinc in Men With Idiopathic Asthenozoospermia. Trials, record NCT05178953. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05178953
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Therapeutic Effect of Co-administration of Pentoxifylline and Zinc in Men With Idiopathic Asthenozoospermia
- NCT number
- NCT05178953
- Status
- Unknown
- Phases
- Early phase 1
- Enrollment
- 160 participants, estimated
- Lead sponsor
- Arak University of Medical Sciences
- Conditions
- Men Infertility
- Interventions
- Zinc Sulfate 220 mg Capsules, Pentoxifylline
- First posted
- 2022-01-05
- Last updated
- 2022-01-05
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | sperm concentration | 1 day | count of sperm(In per million - with the help of a neobar slide and microscopic observation |
| Primary | spem motility | 1 day | motility of sperm: Calculate the percentage of motile sperm using microscopic observation |
| Primary | sperm morphology | 1 day | Calculate the percentage of sperm with a normal shape with the help of Papanic staining |
| Primary | lipid proxidation | One week | Malondialdehyde (nmol/mL), is measured using related experimental kits |
| Primary | reactive oxygen species | One week | eactive oxygen species (ROS (RLU/s)), is measured using related experimental kits |
| Primary | total antioxidant capacity | One week | total antioxidant capacity (TAC (/m / l)) is measured using related experimental kits |
| Primary | FSH hormon | One week | FSH (IU / L) is measured from the blood serum of volunteers using ELISA kit |
| Primary | LH hormon | One week | LH (IU / L) is measured from the blood serum of volunteers using ELISA kit |
| Primary | testosteron hormon [ Time Frame: One week after starting the medication ] testosterone | One week | testosterone (nanomolar per liter) is measured from the blood serum of volunteers using ELISA kit |
| Primary | (Tissue necrosis Factor) | One week | TNF α( Tissue necrosis Factor) (pg/mL) as an inflammatory factor is measured using related experimental kit |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05178953
GET https://conductscience.org/api/trials/v1/NCT05178953/registered